[Cocobalt-60 therapy of urinary bladder carcinoma. 5-year results].
D002293:Adenocarcinoma, Scirrhous / Q000532:radiotherapy; D002277:Carcinoma / Q000532:radiotherapy; D002291:Carcinoma, Papillary / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D002295:Carcinoma, Transitional Cell / Q000532:radiotherapy; D003036:Cobalt Isotopes / Q000627:therapeutic use*; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000532:radiotherapy; D006801:Humans; D008297:Male; D011379:Prognosis; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy*
D003036:Cobalt Isotopes
Kobalt-60-Therapie des Harnblasenkarzinoms. 5-Jahres-Ergebnisse.